• Acute Myeloid Leukemia

Dr. Nicholas Short is an Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas. He attended Baylor College of Medicine for medical school, and then completed internal medicine residency at Brigham and Women’s Hospital, followed by hematology/oncology fellowship at The University of Texas MD Anderson Cancer Center.

Dr. Nicholas Short is a clinical and translational investigator in adult acute leukemias, with a particular emphasis on the prognostic and therapeutic impact of measurable residual disease (MRD) and the development of phase I and II clinical trials of novel agents and combinations for patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). He serves as principal investigator or co-principal investigator on over a dozen phase I and II clinical trials and has authored over 200 peer-reviewed manuscripts and numerous abstracts that have been presented at national and international conferences, including the American Society of Hematology and the American Society of Clinical Oncology.

For his accomplishments in the field of leukemia research he has received a number of awards, including the American Society of Clinical Oncology Young Investigator Award and the American Society of Hematology Junior Faculty Scholar Award in Clinical Research.